ATE499612T1 - Verwendung eines endoplasmin-fragments und von derivaten davon als biomarker für kolorektaladenom und/oder -karzinom; nachweisverfahren und testsystem - Google Patents

Verwendung eines endoplasmin-fragments und von derivaten davon als biomarker für kolorektaladenom und/oder -karzinom; nachweisverfahren und testsystem

Info

Publication number
ATE499612T1
ATE499612T1 AT05778104T AT05778104T ATE499612T1 AT E499612 T1 ATE499612 T1 AT E499612T1 AT 05778104 T AT05778104 T AT 05778104T AT 05778104 T AT05778104 T AT 05778104T AT E499612 T1 ATE499612 T1 AT E499612T1
Authority
AT
Austria
Prior art keywords
carcinoma
colorectal
colorectal adenoma
test system
biomarker
Prior art date
Application number
AT05778104T
Other languages
English (en)
Inventor
Hartmut Juhl
Kerstin David
Anne-Kristin Fentz
Original Assignee
Indivumed Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indivumed Gmbh filed Critical Indivumed Gmbh
Application granted granted Critical
Publication of ATE499612T1 publication Critical patent/ATE499612T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57535—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the large intestine, e.g. colon, rectum or anus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/57595—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving intracellular compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
AT05778104T 2005-08-19 2005-08-19 Verwendung eines endoplasmin-fragments und von derivaten davon als biomarker für kolorektaladenom und/oder -karzinom; nachweisverfahren und testsystem ATE499612T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2005/009005 WO2007019875A1 (en) 2005-08-19 2005-08-19 Use of an endoplasmin fragment and derivatives thereof as a biomarker for colorectal adenoma and/or carcinoma; method for detection and test system

Publications (1)

Publication Number Publication Date
ATE499612T1 true ATE499612T1 (de) 2011-03-15

Family

ID=36087694

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05778104T ATE499612T1 (de) 2005-08-19 2005-08-19 Verwendung eines endoplasmin-fragments und von derivaten davon als biomarker für kolorektaladenom und/oder -karzinom; nachweisverfahren und testsystem

Country Status (13)

Country Link
US (1) US8580489B2 (de)
EP (1) EP1917530B1 (de)
JP (1) JP4832519B2 (de)
KR (1) KR101314959B1 (de)
AT (1) ATE499612T1 (de)
AU (1) AU2005335652A1 (de)
BR (1) BRPI0520483A2 (de)
CA (1) CA2617214C (de)
DE (1) DE602005026587D1 (de)
IL (1) IL189185A0 (de)
MX (1) MX2008001818A (de)
NO (1) NO20080510L (de)
WO (1) WO2007019875A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2126579A2 (de) * 2007-02-27 2009-12-02 Sentoclone AB Multiplex-nachweis von tumorzellen unter verwendung einer gruppe von an extrazelluläre marker bindenden agentien
CN109584961A (zh) * 2018-12-03 2019-04-05 元码基因科技（北京）股份有限公司 基于二代测序技术检测血液微卫星不稳定的方法
CN110244047B (zh) * 2019-06-10 2023-11-03 广州市妇女儿童医疗中心 肺癌血清诊断标志物及其应用、肺癌相关可溶性蛋白的分离鉴定方法
KR102735773B1 (ko) * 2022-11-10 2024-11-27 을지대학교 산학협력단 혈액 내 단백질 바이오마커를 포함하는 암 진단용 키트

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10019967A1 (de) * 2000-04-20 2001-10-25 Fenning Biomed Gmbh Dr Antikörper gegen natives gp96, deren Herstellung und Verwendung
MXPA05006382A (es) 2002-12-20 2005-10-24 Hoffmann La Roche Uso de nicotinamida n-metiltransferasa como un marcador para cancer colorrectal.
US8067152B2 (en) * 2006-02-27 2011-11-29 The Fred Hutchinson Cancer Research Center Liver cancer biomarkers

Also Published As

Publication number Publication date
US8580489B2 (en) 2013-11-12
EP1917530B1 (de) 2011-02-23
NO20080510L (no) 2008-05-19
WO2007019875A1 (en) 2007-02-22
BRPI0520483A2 (pt) 2009-11-10
CA2617214A1 (en) 2007-02-22
EP1917530A1 (de) 2008-05-07
KR101314959B1 (ko) 2013-10-11
CA2617214C (en) 2013-02-12
AU2005335652A1 (en) 2007-02-22
US20100273668A1 (en) 2010-10-28
DE602005026587D1 (de) 2011-04-07
KR20080036652A (ko) 2008-04-28
MX2008001818A (es) 2008-04-09
JP2009505080A (ja) 2009-02-05
JP4832519B2 (ja) 2011-12-07
IL189185A0 (en) 2008-06-05

Similar Documents

Publication Publication Date Title
IL181131A0 (en) USE OF C3a AND DERIVATIVES THEREOF AS A BIOMARKER FOR COLORECTAL ADEMONA AND/OR CARCINOMA; DIAGNOSIS METHOD AND TEST SYSTEM USING THE SAME
MX357550B (es) Microarn plasmaticos para la deteccion de cancer colorrectal temprano.
DE60332639D1 (de) Verwendung von biomarkern zum nachweis von eierstockkrebs
WO2007090076A3 (en) Methods for identifying patients with an increased likelihood of having ovarian cancer and compositions therefor
EP3156925A3 (de) Copd-biomarkersignaturen
WO2008109075A3 (en) Biomarkers and methods for determining sensitivity to ctla-4 antagonists
ATE556030T1 (de) Ultrasensitiver nachweis von analyten
WO2010033371A3 (en) Molecular markers for lung and colorectal carcinomas
ATE408829T1 (de) Verfahren und assaykits zum nachweis mononuklearer zellphänotypen
EA200500355A1 (ru) Способ обнаружения, характеристики и мониторинга углеводородных месторождений
ATE492815T1 (de) Diagnostik-biomolekül(e)
ATE370414T1 (de) Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs
IL189185A0 (en) Use of an endoplasmin fragment and derivatives thereof as a biomarker for colorectal adenoma and/or carcinoma; method for detection and test system
WO2014044791A3 (en) Methods and kits for predicting the sensitivity of a subject to chemotherapy
ZA202309599B (en) Biomarkers of musculoskeletal injury
DE602005013430D1 (de) Verwendung von asc als marker für kolorektalkarzinome
WO2011035249A3 (en) Methods for detecting thrombocytosis using biomarkers
NO20053276L (no) Fremgangsmate og hjelpemiddel for pavisning av mykoplasma.
DK1416278T3 (da) Fremgangsmåder til forbedret diagnosticering af dysplasier
WO2007062142A3 (en) Method for identifying biomarkers associated with cancer
BRPI0514314A (pt) método para detecção de e discriminação entre adenoma colorretal e/ou carcinoma colorretal, método para monitoramento de desenvolvimento e/ou curso e/ou de tratamento de adenoma colorretal e/ou carcinoma colorretal, uso de c3a ou derivado do mesmo, sistema de teste, conjunto compreendendo moléculas, método para determinar se um composto é efetivo no tratamento do adenoma colorretal e/ou carcinoma colorretal
EP1852513A3 (de) Verfahren zur Krebsdiagnose mittels Genmarker für krebsassoziierte Deletionen
RU2007119984A (ru) Способ контроля аналитической работы при опробовании золоторудных месторождений

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties